Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
Patient was vaccinated with Capvaxive on 3/12/26 and a second dose was administered on 3/13/26. Patient does not report any adverse effects as of 3/23/2026.